Literature DB >> 11474123

Vdelta1 T lymphocytes expressing a Th1 phenotype are the major gammadelta T cell subset infiltrating the liver of HCV-infected persons.

C Agrati1, G D'Offizi, P Narciso, S Abrignani, G Ippolito, V Colizzi, F Poccia.   

Abstract

BACKGROUND: Hepatitis C infection induces an acute and chronic liver inflammation that may lead to cirrhosis, liver failure, or hepatocarcinoma. Since the role of alphabeta T lymphocytes in hepatitis C virus (HCV) immunopathology has been analyzed extensively, we investigated the distribution and functional activation of gammadelta T cell subsets in chronically HCV-infected patients.
MATERIALS AND METHODS: Blood samples and liver biopsies from 35 patients with compensated chronic HCV infection were compared in terms of T cell subset distribution, expression of activation markers, gammadelta T cell receptor (TCR) repertoire, and pattern of cytokine production. Moreover, we analyzed whether these immunological parameters were associated with other clinical observations (plasma viremia, ALT levels, Ishak index).
RESULTS: Differing from peripheral blood distribution, a specific compartmentalization of Vdelta1 T cells (p < 0.001) was observed in the liver of HCV patients. These cells represented a relevant fraction of intrahepatic T lymphocytes (1.8-8.7%) and expressed the memory/effector phenotype (CD62-L- CD45-RO+CD95+). This phenotype was consistent with selective homing upon antigen recognition. Mitogenic stimulation of Vdelta1 + T lymphocytes recruited in the liver revealed the T helper cell type 1 (Th1) pattern of cytokine secretion. Interestingly, the frequency of interferon-gamma (IFN-gamma)-producing Vdelta1 T cells was associated with an higher degree of liver necroinflammation, measured by the Ishak index. Finally, the T-cell repertoire analysis revealed the absence of Vgamma selection in the TCR repertoire of intrahepatic Vdelta1 T cells.
CONCLUSIONS: gammadelta T cell distribution in the peripheral blood differs from the Vdelta1 T cell subset because it is policlonally activated and recruited in the liver of chronic HCV-infected patients. During HCV-infection, this T cell subset may release Th1 cytokines and contribute to the necroinflammatory liver disease.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11474123      PMCID: PMC1949990     

Source DB:  PubMed          Journal:  Mol Med        ISSN: 1076-1551            Impact factor:   6.354


  23 in total

Review 1.  Biological characteristics and biomarkers of novel SARS-CoV-2 facilitated rapid development and implementation of diagnostic tools and surveillance measures.

Authors:  Gajanan Sampatrao Ghodake; Surendra Krushna Shinde; Avinash Ashok Kadam; Rijuta Ganesh Saratale; Ganesh Dattatraya Saratale; Asad Syed; Abdallah M Elgorban; Najat Marraiki; Dae-Young Kim
Journal:  Biosens Bioelectron       Date:  2021-01-04       Impact factor: 10.618

2.  γδ T Cells Contribute to the Outcome of Murine Fulminant Viral Hepatitis via Effector Cytokines TNF-α and IFN-γ.

Authors:  Di Wu; Wei-Ming Yan; Hong-Wu Wang; Da Huang; Xiao-Ping Luo; Qin Ning
Journal:  Curr Med Sci       Date:  2018-08-20

3.  Elevation of Vδ1 T cells in peripheral blood and livers of patients with primary biliary cholangitis.

Authors:  F Hua; L Wang; X Rong; Y Hu; J M Zhang; W He; F C Zhang
Journal:  Clin Exp Immunol       Date:  2016-09-09       Impact factor: 4.330

4.  Composition of inflammatory infiltrate and its correlation with HBV/HCV antigen expression.

Authors:  Bozena Walewska-Zielecka; Kazimierz Madalinski; Joanna Jablonska; Paulina Godzik; Joanna Cielecka-Kuszyk; Bogumila Litwinska
Journal:  World J Gastroenterol       Date:  2008-07-07       Impact factor: 5.742

Review 5.  Role of gamma-delta T cells in liver inflammation and fibrosis.

Authors:  Linda Hammerich; Frank Tacke
Journal:  World J Gastrointest Pathophysiol       Date:  2014-05-15

6.  Aedes aegypti saliva alters leukocyte recruitment and cytokine signaling by antigen-presenting cells during West Nile virus infection.

Authors:  Bradley S Schneider; Lynn Soong; Lark L Coffey; Heather L Stevenson; Charles E McGee; Stephen Higgs
Journal:  PLoS One       Date:  2010-07-22       Impact factor: 3.240

Review 7.  Key Features of Gamma-Delta T-Cell Subsets in Human Diseases and Their Immunotherapeutic Implications.

Authors:  Myriam Lawand; Julie Déchanet-Merville; Marie-Caroline Dieu-Nosjean
Journal:  Front Immunol       Date:  2017-06-30       Impact factor: 7.561

Review 8.  Human gamma delta T cells: candidates for the development of immunotherapeutic strategies.

Authors:  Susann Beetz; Lothar Marischen; Dieter Kabelitz; Daniela Wesch
Journal:  Immunol Res       Date:  2007       Impact factor: 4.505

9.  A dynamic COVID-19 immune signature includes associations with poor prognosis.

Authors:  Adam G Laing; Anna Lorenc; Irene Del Molino Del Barrio; Abhishek Das; Matthew Fish; Leticia Monin; Miguel Muñoz-Ruiz; Duncan R McKenzie; Thomas S Hayday; Isaac Francos-Quijorna; Shraddha Kamdar; Magdalene Joseph; Daniel Davies; Richard Davis; Aislinn Jennings; Iva Zlatareva; Pierre Vantourout; Yin Wu; Vasiliki Sofra; Florencia Cano; Maria Greco; Efstathios Theodoridis; Joshua D Freedman; Sarah Gee; Julie Nuo En Chan; Sarah Ryan; Eva Bugallo-Blanco; Pärt Peterson; Kai Kisand; Liis Haljasmägi; Loubna Chadli; Philippe Moingeon; Lauren Martinez; Blair Merrick; Karen Bisnauthsing; Kate Brooks; Mohammad A A Ibrahim; Jeremy Mason; Federico Lopez Gomez; Kola Babalola; Sultan Abdul-Jawad; John Cason; Christine Mant; Jeffrey Seow; Carl Graham; Katie J Doores; Francesca Di Rosa; Jonathan Edgeworth; Manu Shankar-Hari; Adrian C Hayday
Journal:  Nat Med       Date:  2020-08-17       Impact factor: 87.241

Review 10.  Gamma Delta T-lymphocytes in Hepatitis C and Chronic Liver Disease.

Authors:  Neil Rajoriya; Joannah Ruth Fergusson; Joanna A Leithead; Paul Klenerman
Journal:  Front Immunol       Date:  2014-08-26       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.